Oral lichenoid tissue reactions: diagnosis and classification

References

• Pinkus H. Lichenoid tissue reactions. A speculative review of the clinical spectrum of epidermal basal cell damage with special reference to erythema dyschromicum perstans. Arch Dermatol 1973;107(6):840-6
   PubMedGoogle Scholar
• Sontheimer RD. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 2009;129(5):1088-99
   PubMed Web of Science ®Google Scholar
• Schlosser BJ. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther 2010;23(3):251-67
   PubMedGoogle Scholar
• Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl):S25. e21-12
   PubMedGoogle Scholar
• Cortes-Ramirez DA, Gainza-Cirauqui ML, Echebarria-Goikouria MA, Aguirre-Urizar JM. Oral lichenoid disease as a premalignant condition: the controversies and the unknown. Med Oral Patol Oral Cir Bucal 2009;14(3):E118-22
   PubMedGoogle Scholar
• Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007;49(2):89-106
   PubMedGoogle Scholar
• van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003;32(9):507-12
   PubMed Web of Science ®Google Scholar
• Carrozzo M, Thorpe R. Oral lichen planus: a review. Minerva Stomatol 2009;58(10):519-37
   PubMedGoogle Scholar
• Aguirre Urizar JM. Letter to the editor: oral lichenoid disease. A new classification proposal. Med Oral Patol Oral Cir Bucal 2008;13(4):E224
   PubMedGoogle Scholar
• van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal 2009;14(7):E310-14
   PubMedGoogle Scholar
• Scully C, Carrozzo M. Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 2008;46(1):15-21
   PubMed Web of Science ®Google Scholar
• Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V Oral lichen planus: clinical features and management. Oral Dis 2005;11(6):338-49
   PubMed Web of Science ®Google Scholar
• Rodstrom PO, Jontell M, Mattsson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol 2004;40(2):131-8
   PubMedGoogle Scholar
• Carrozzo M, Uboldi de Capei M, Dametto E, et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 2004;122(1):87-94
   PubMedGoogle Scholar
• Jin X, Wang J, Zhu L, et al. Association between -308 G/A polymorphism in TNF-alpha gene and lichen planus: a meta-analysis. J Dermatol Sci 2012;68(3):127-34
   PubMedGoogle Scholar
• Thornhill MH, Pemberton MN, Simmons RK, Theaker ED. Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95(3):291-9
   PubMedGoogle Scholar
• Shengyuan L, Songpo Y, Wen W, et al. Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol 2009;145(9):1040-7
   PubMedGoogle Scholar
• Lodi G, Pellicano R, Carrozzo M. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis 2010;16(7):601-12
   PubMed Web of Science ®Google Scholar
• Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011;99(2):168-78
   PubMed Web of Science ®Google Scholar
• Pilli M, Penna A, Zerbini A, et al. Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology 2002;36(6):1446-52
   PubMed Web of Science ®Google Scholar
• Holmstrup P, Thorn JJ, Rindum J, Pindborg JJ. Malignant development of lichen planus-affected oral mucosa. J Oral Pathol 1988;17(5):219-25
   PubMedGoogle Scholar
• Gandolfo S, Richiardi L, Carrozzo M, et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 2004;40(1):77-83
   PubMedGoogle Scholar
• Helander SD, Rogers RS 3rd. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 1994;30(1):65-75
   PubMed Web of Science ®Google Scholar
• Calabresi V, Carrozzo M, Cozzani E, et al. Oral pemphigoid autoantibodies preferentially target BP180 ectodomain. Clin Immunol 2007;122(2):207-13
   PubMedGoogle Scholar
• Carrozzo M. A reappraisal of diagnostic criteria for mucous membrane pemphigoid. J Oral Pathol Med 2009;38(1):160
   PubMedGoogle Scholar
• Buijsrogge JJ, Hagel C, Duske U, et al. IgG antibodies to BP180 in a subset of oral lichen planus patients. J Dermatol Sci 2007;47(3):256-8
   PubMedGoogle Scholar
• Baccaglini L, Thongprasom K, Carrozzo M, Bigby M. Urban legends series: lichen planus. Oral Dis 2013;19(2):128-43
   PubMedGoogle Scholar
• McParland H, Warnakulasuriya S. Oral lichenoid contact lesions to mercury and dental amalgam – a review. J Biomed Biotechnol 2012;2012:589569
   PubMedGoogle Scholar
• Jensen SJ. Maximum contents of mercury in dental silver amalgams. Scand J Dent Res 1985;93(1):84-8
   PubMedGoogle Scholar
• Dunsche A, Frank MP, Luttges J, et al. Lichenoid reactions of murine mucosa associated with amalgam. Br J Dermatol 2003;148(4):741-8
   PubMedGoogle Scholar
• Seno K, Ohno J, Ota N, et al. Lupus-like oral mucosal lesions in mercury-induced autoimmune response in Brown Norway rats. BMC Immunol 2013;14:47
   PubMedGoogle Scholar
• Holmstrup P. Reactions of the oral mucosa related to silver amalgam: a review. J Oral Pathol Med 1991;20(1):1-7
   PubMedGoogle Scholar
• Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27(2):175-81
   PubMed Web of Science ®Google Scholar
• von Blomberg-van der Flier M, van der Burg CK, Pos O, et al. In vitro studies in nickel allergy: diagnostic value of a dual parameter analysis. J Invest Dermatol 1987;88(4):362-8
   PubMedGoogle Scholar
• Cederbrant K, Gunnarsson LG, Hultman P, et al. In vitro lymphoproliferative assays with HgCl2 cannot identify patients with systemic symptoms attributed to dental amalgam. J Dent Res 1999;78(8):1450-8
   PubMedGoogle Scholar
• McCartan BE, McCreary CE. Oral lichenoid drug eruptions. Oral Dis 1997;3(2):58-63
   PubMedGoogle Scholar
• Thompson DF, Skaehill PA. Drug-induced lichen planus. Pharmacotherapy 1994;14(5):561-71
   PubMedGoogle Scholar
• Lamey PJ, McCartan BE, MacDonald DG, MacKie RM. Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79(1):44-9
   PubMedGoogle Scholar
• Van den Haute V, Antoine JL, Lachapelle JM. Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 1989;179(1):10-13
   PubMedGoogle Scholar
• McCartan BE, Lamey P. Lichen planus – specific antigen in oral lichen planus and oral lichenoid drug eruptions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(5):585-7
   PubMedGoogle Scholar
• Dickinson AM, Sviland L, Wang XN, et al. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model. Transplantation 1998;66(7):857-63
   PubMedGoogle Scholar
• Wang XN, Collin M, Sviland L, et al. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors. Biol Blood Marrow Transplant 2006;12(2):152-9
   PubMedGoogle Scholar
• Imanguli MM, Alevizos I, Brown R, et al. Oral graft-versus-host disease. Oral Dis 2008;14(5):396-412
   PubMed Web of Science ®Google Scholar
• Filipovich AH. Diagnosis and manifestations of chronic graft-versus-host disease. Best Pract Res Clin Haematol 2008;21(2):251-7
   PubMedGoogle Scholar
• Woo SB, Lee SJ, Schubert MM. Graft-vs.-host disease. Crit Rev Oral Biol Med 1997;8(2):201-16
   PubMedGoogle Scholar
• Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323(25):1729-35
   PubMed Web of Science ®Google Scholar
• Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001;137(2):193-206
   PubMedGoogle Scholar
• Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol 2003;149(6):1143-51
   PubMedGoogle Scholar
• Schepens I, Jaunin F, Begre N, et al. The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS One 2010;5(8):e12250
   PubMedGoogle Scholar
• Martel P, Loiseau P, Joly P, et al. Paraneoplastic pemphigus is associated with the DRB1*03 allele. J Autoimmun 2003;20(1):91-5
   PubMedGoogle Scholar
• Liu Q, Bu DF, Li D, Zhu XJ. Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus. Br J Dermatol 2008;158(3):587-91
   PubMedGoogle Scholar
• Liu AY, Valenzuela R, Helm TN, et al. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 1993;28(5 Pt 1):696-9
   PubMedGoogle Scholar
• Helou J, Allbritton J, Anhalt GJ. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995;32(3):441-7
   PubMedGoogle Scholar
• Probst C, Schlumberger W, Stocker W, et al. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta 2009;410(1-2):13-18
   PubMedGoogle Scholar
• Poot AM, Diercks GF, Kramer D, et al. Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol 2013;169(5):1016-24
   PubMed Web of Science ®Google Scholar
• Nieboer C. The reliability of immunofluorescence and histopathology in the diagnosis of discoid lupus erythematosus and lichen planus. Br J Dermatol 1987;116(2):189-98
   PubMedGoogle Scholar
• Nagao K, Chen KR. A case of lupus erythematosus/lichen planus overlap syndrome. J Dermatol 2006;33(3):187-90
   PubMedGoogle Scholar
• Oke V, Wahren-Herlenius M. Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis. J Intern Med 2013;273(6):544-54
   PubMedGoogle Scholar
• Jarvinen TM, Hellquist A, Koskenmies S, et al. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus. Exp Dermatol 2010;19(2):123-31
   PubMedGoogle Scholar
• Jarvinen TM, Hellquist A, Koskenmies S, et al. Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus. PLoS One 2010;5(12):e14212
   PubMedGoogle Scholar
• Namjou B, Kothari PH, Kelly JA, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 2011;12(4):270-9
   PubMed Web of Science ®Google Scholar
• Jessop S, Whitelaw DA, Delamere FM. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev 2009;4: Cd002954
   Google Scholar
• Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009;10(6):365-81
   PubMed Web of Science ®Google Scholar
• Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol 2006;47(1):13-27
   PubMed Web of Science ®Google Scholar
• Merola JF, Prystowsky SD, Iversen C, et al. Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol 2013;69(1):19-24
   PubMedGoogle Scholar
• Uva L, Miguel D, Pinheiro C, et al. Cutaneous manifestations of systemic lupus erythematosus. Autoimmune Dis 2012;2012:834291
   PubMedGoogle Scholar
• Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev 2005;4(5):296-302
   PubMedGoogle Scholar
• Thorne JE, Jabs DA, Nikolskaia O, et al. Discoid lupus erythematosus and cicatrizing conjunctivitis: clinicopathologic study of two cases. Ocul Immunol Inflamm 2002;10(4):287-92
   PubMed Web of Science ®Google Scholar
• Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 2006;24(5):348-62
   PubMed Web of Science ®Google Scholar
• Chong BF, Song J, Olsen NJ. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. Br J Dermatol 2012;166(1):29-35
   PubMed Web of Science ®Google Scholar
• Nico MM, Vilela MA, Rivitti EA, Lourenco SV. Oral lesions in lupus erythematosus: correlation with cutaneous lesions. Eur J Dermatol 2008;18(4):376-81
   PubMedGoogle Scholar
• Tao D, Shangwu L, Yan L, et al. Retraction: CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol 2012;188(11):5800
   PubMedGoogle Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25(11):1271-7
   PubMed Web of Science ®Google Scholar
• Lee JS, Haug BL, Sibley JT. Decreased mRNA levels coding for poly(ADP-ribose) polymerase in lymphocytes of patients with SLE. Lupus 1994;3(2):113-16
   PubMed Web of Science ®Google Scholar
• Chong BF, Tseng LC, Lee T, et al. IgG and IgM autoantibody differences in discoid and systemic lupus patients. J Invest Dermatol 2012;132(12):2770-9
   PubMed Web of Science ®Google Scholar
• Hung T, Ian Crawford R, Martinka M. Degree of histologic inflammation in lupus erythematosus and direct immunofluorescence results: red and inflamed lesions do not increase the chances of getting a bright band. J Cutan Med Surg 2013;17(1):22-6
   PubMedGoogle Scholar
• Harley IT, Kaufman KM, Langefeld CD, et al. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009;10(5):285-90
   PubMed Web of Science ®Google Scholar
• Fernando MM, Stevens CR, Sabeti PC, et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007;3(11):e192
   PubMed Web of Science ®Google Scholar
• Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;40(2):204-10
   PubMed Web of Science ®Google Scholar
• Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum 1999;42(9):1785-96
   PubMedGoogle Scholar
• Jonsson R, Heyden G, Westberg NG, Nyberg G. Oral mucosal lesions in systemic lupus erythematosus – a clinical, histopathological and immunopathological study. J Rheumatol 1984;11(1):38-42
   PubMedGoogle Scholar
• Jorizzo JL, Salisbury PL, Rogers RS 3rd, et al. Oral lesions in systemic lupus erythematosus. Do ulcerative lesions represent a necrotizing vasculitis? J Am Acad Dermatol 1992;27(3):389-94
   PubMedGoogle Scholar
• McCauliffe DP. Cutaneous lupus erythematosus. Semin Cutan Med Surg 2001;20(1):14-26
   PubMedGoogle Scholar
• Fritzler MJ. Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Autoimmunity Highlights 2012;3(2):51-8
   PubMedGoogle Scholar
• Licarete E, Ganz S, Recknagel MJ, et al. Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases. BMC Immunol 2012;13:16
   PubMed Web of Science ®Google Scholar
• Jaremko WM, Beutner EH, Kumar V, et al. Chronic ulcerative stomatitis associated with a specific immunologic marker. J Am Acad Dermatol 1990;22(2 Pt 1):215-20
   PubMedGoogle Scholar
• Worle B, Wollenberg A, Schaller M, et al. Chronic ulcerative stomatitis. Br J Dermatol 1997;137(2):262-5
   PubMedGoogle Scholar
• Chorzelski TP, Olszewska M, Jarzabek-Chorzelska M, Jablonska S. Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases. Eur J Dermatol 1998;8(4):261-5
   PubMedGoogle Scholar
• Solomon LW, Aguirre A, Neiders M, et al. Chronic ulcerative stomatitis: clinical, histopathologic, and immunopathologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96(6):718-26
   PubMedGoogle Scholar
• Islam MN, Cohen DM, Ojha J, et al. Chronic ulcerative stomatitis: diagnostic and management challenges – four new cases and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(2):194-203
   PubMedGoogle Scholar
• Solomon LW. Chronic ulcerative stomatitis. Oral Dis 2008;14(5):383-9
   PubMedGoogle Scholar
• Cozzani E, Cacciapuoti M, di Marco E, et al. Patients with oral erosive and cutaneous lichen planus may have antibodies directed against the chronic ulcerative stomatitis protein antigen of 70-kDa. Acta Dermatovenerol Alp Panonica Adriat 2008;17(3):120-4
   PubMedGoogle Scholar
• Solomon LW, Stark PC, Winter L, et al. ELISA test for p63 antibodies in chronic ulcerative stomatitis. Oral Dis 2010;16(2):151-5
   PubMedGoogle Scholar
• Carlson MW, Garlick JA, Solomon LW. Chronic ulcerative stomatitis: evidence of autoimmune pathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111(6):742-8
   PubMedGoogle Scholar
• Fourie J, van Heerden WF, McEachen SC, van Zyl A. Chronic ulcerative stomatitis: a distinct clinical entity? SADJ 2011;66(3):119-21
   PubMedGoogle Scholar
• Rinaggio J, Crossland DM, Zeid MY. A determination of the range of oral conditions submitted for microscopic and direct immunofluorescence analysis. J Periodontol 2007;78(10):1904-10
   PubMedGoogle Scholar
• Parodi A, Cozzani E, Chorzelski TP, et al. A molecule of about 70 kd is the immunologic marker of chronic ulcerative stomatitis. J Am Acad Dermatol 1998;38(6 Pt 1):1005-6
   PubMedGoogle Scholar
• Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 1998;16(3):379-87
   PubMedGoogle Scholar
• Carrizosa AM, Elorza FL, Camacho FM. Antinuclear antibodies in patients with lichen planus. Exp Dermatol 1997;6(1):54-6
   PubMedGoogle Scholar
• Cacciapuoti M, Di Marco E, Cozzani E, et al. The antibody to the 70-kd antigen in chronic ulcerative stomatitis and lichen planus. J Am Acad Dermatol 2004;50(3):486
   PubMedGoogle Scholar
• Parodi A, Cozzani E, Massone C, et al. Prevalence of stratified epithelium-specific antinuclear antibodies in 138 patients with lichen planus. J Am Acad Dermatol 2007;56(6):974-8
   PubMedGoogle Scholar
• Lee LA, Walsh P, Prater CA, et al. Characterization of an autoantigen associated with chronic ulcerative stomatitis: the CUSP autoantigen is a member of the p53 family. J Invest Dermatol 1999;113(2):146-51
   PubMedGoogle Scholar
• Choi HR, Batsakis JG, Zhan F, et al. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002;33(2):158-64
   PubMedGoogle Scholar
• Solomon LW, Helm TN, Stevens C, et al. Clinical and immunopathologic findings in oral lichen planus pemphigoides. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(6):808-13
   PubMedGoogle Scholar
• Ebrahimi M, Nylander E, Backlund B, et al. The use of a novel ELISA method for detection of antibodies against p63 in sera from patients diagnosed with oral and/or genital and skin lichen planus. J Oral Pathol Med 2010;39(6):486-90
   PubMedGoogle Scholar
• Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 2011;7(6):803-13. quiz 814-805
   PubMed Web of Science ®Google Scholar
• Carrozzo M, Togliatto M, Gandolfo S. [Erythema multiforme. A heterogeneous pathologic phenotype]. Minerva Stomatol 1999;48(5):217-26
   PubMedGoogle Scholar
• Dumas V, Thieulent N, Souillet AL, et al. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Br J Dermatol 2000;142(6):1248-9
   PubMedGoogle Scholar
• Ozkaya E. Oral mucosal fixed drug eruption: characteristics and differential diagnosis. J Am Acad Dermatol 2013;69(2):e51-8
   PubMedGoogle Scholar
• Webster K, Godbold P. Nicorandil induced oral ulceration. Br Dent J 2005;198(10):619-21
   PubMedGoogle Scholar
• Oyama N, Setterfield JF, Gratian MJ, et al. Oral and genital lichenoid reactions associated with circulating autoantibodies to desmoplakins I and II: a novel target antigen or example of epitope spreading? J Am Acad Dermatol 2003;48(3):433-8
   PubMedGoogle Scholar
• Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis 2005;11(5):261-7
   PubMedGoogle Scholar
• Scully C, Bagan J. Oral mucosal diseases: erythema multiforme. Br J Oral Maxillofac Surg 2008;46(2):90-5
   PubMedGoogle Scholar
• Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am 2005;49(1):67-76. viii
   PubMedGoogle Scholar
• Khalil I, Lepage V, Douay C, et al. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. J Invest Dermatol 1991;97(4):697-700
   PubMedGoogle Scholar
• Profaizer T, Eckels D. HLA alleles and drug hypersensitivity reactions. Int J Immunogenet 2012;39(2):99-105
   PubMedGoogle Scholar
• de Roux Serratrice C, Serratrice J, Granel B, et al. [Stevens-Johnson syndrome followed by Gougerot-Sjogren syndrome]. Presse Med 2001;30(11):531-2
   PubMedGoogle Scholar
• Foedinger D, Anhalt GJ, Boecskoer B, et al. Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 1995;181(1):169-79
   PubMedGoogle Scholar
• Hinterhuber G, Binder M, Marquardt Y, et al. Enzyme-linked immunosorbent assay for detection of peptide-specific human antidesmoplakin autoantibodies. Br J Dermatol 2005;153(2):413-16
   PubMedGoogle Scholar
• Cozzani E, Di Zenzo G, Calabresi V, et al. Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon? Eur J Dermatol 2011;21(1):32-6
   PubMedGoogle Scholar
• Johnson SM, Smoller BR, Horn TD. Erythema multiforme associated human autoantibodies against desmoplakin I and II. J Invest Dermatol 1999;112(3):395-6
   PubMedGoogle Scholar
• Washio K, Nakamura A, Fukuda S, et al. A case of lichen planus pemphigoides successfully treated with a combination of cyclosporine a and prednisolone. Case Rep Dermatol 2013;5(1):84-7
   PubMedGoogle Scholar
• Zaraa I, Mahfoudh A, Sellami MK, et al. Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol 2013;52(4):406-12
   PubMed Web of Science ®Google Scholar
• Mignogna MD, Fortuna G, Leuci S, et al. Lichen planus pemphigoides, a possible example of epitope spreading. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):837-43
   PubMedGoogle Scholar
• Lee HY, Blazek C, Beltraminelli H, Borradori L. Oral mucous membrane pemphigoid: complete response to topical tacrolimus. Acta Derm Venereol 2011;91(5):604-5
   PubMedGoogle Scholar
• Hamada T, Fujimoto W, Okazaki F, et al. Lichen planus pemphigoides and multiple keratoacanthomas associated with colon adenocarcinoma. Br J Dermatol 2004;151(1):252-4
   PubMedGoogle Scholar
• Stoebner PE, Michot C, Ligeron C, et al. [Simvastatin-induced lichen planus pemphigoides]. Ann Dermatol Venereol 2003;130(2 Pt 1):187-90
   PubMedGoogle Scholar
• Noel B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol 2007;21(1):17-24
   PubMedGoogle Scholar
• Maoz KB, Brenner S. Lichen planus pemphigoides triggered by narrowband UVB, paracetamol, and ibuprofen, with autoantibodies to 130kDa antigen. Skinmed 2008;7(1):33-6
   PubMedGoogle Scholar
• Cohen DM, Ben-Amitai D, Feinmesser M, Zvulunov A. Childhood lichen planus pemphigoides: a case report and review of the literature. Pediatr Dermatol 2009;26(5):569-74
   PubMedGoogle Scholar
• Tamada Y, Yokochi K, Nitta Y, et al. Lichen planus pemphigoides: identification of 180 kd hemidesmosome antigen. J Am Acad Dermatol 1995;32(5 Pt 2):883-7
   PubMedGoogle Scholar
• Sapadin AN, Phelps RG, Fellner MJ, Kantor I. Lichen planus pemphigoides presenting with a strikingly unilateral distribution. Int J Dermatol 1998;37(12):942-6
   PubMedGoogle Scholar
• Yoon KH, Kim SC, Kang DS, Lee IJ. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens. Eur J Dermatol 2000;10(3):212-14
   PubMedGoogle Scholar
• Zillikens D, Caux F, Mascaro JM, et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999;113(1):117-21
   PubMedGoogle Scholar
• Barnadas MA, Roe E, Dalmau J, et al. Lichen planus pemphigoides: detection of anti-BP 180 antibodies by ELISA and immunoblotting tests. J Eur Acad Dermatol Venereol 2010;24(11):1360-1
   PubMedGoogle Scholar
• Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69(8):1420-2
   PubMed Web of Science ®Google Scholar
• Dutz JP. T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction. J Invest Dermatol 2009;129(2):309-14
   PubMedGoogle Scholar
• Fan W, Liang D, Tang Y, et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum 2012;64(11):3715-25
   PubMedGoogle Scholar
• Gassling V, Hampe J, Acil Y, et al. Disease-associated miRNA-mRNA networks in oral lichen planus. PLoS One 2013;8(5):e63015
   PubMedGoogle Scholar